CXCL1 and ovarian cancer: Furthermore, we measured the expression of receptors for CXCL1 and CXCL8 in ovarian cancer cells and demonstrated that specific antibodies, receptor inhibitors, and CXCL8 antibodies SB225002 and SB265610, significantly inhibited ovarian cancer cell invasion induced by epinephrine.